Live vs inactivated vaccines: eligibility, pregnancy, immunosuppression and teaching

Ask one question first: can the vaccine organism replicate?

The most useful distinction is replication. A live attenuated vaccine uses a weakened organism that multiplies in the body and produces a strong immune response, but in a person whose immune system cannot contain it, that replication can become a real infection. Inactivated, subunit, toxoid and recombinant vaccines cannot multiply, so the infection risk from the vaccine itself is not the concern.

For exam purposes, sort the vaccine before you sort the patient. Common live examples are measles, mumps and rubella, varicella, the combined MMRV product, the nasal spray influenza vaccine, rotavirus and yellow fever. Injectable influenza, Tdap, hepatitis A and B, HPV, pneumococcal and inactivated polio vaccines are non-live. The recombinant shingles vaccine is also non-live, which commonly confuses candidates.

Pregnancy: defer live vaccines and give recommended non-live ones

CDC guidance states that live attenuated vaccines are generally not given to a person known to be pregnant because of a theoretical risk to the fetus. A non-immune pregnant patient therefore has MMR or varicella deferred until after birth, and is taught to avoid conceiving for about one month after receiving either vaccine. Breastfeeding is generally not a reason to delay postpartum MMR.

The opposite error also appears in questions: withholding every vaccine in pregnancy. Inactivated influenza vaccine is recommended in any trimester, and Tdap is recommended during each pregnancy so that antibodies pass to the infant. A strong answer separates the two categories rather than treating pregnancy as a blanket reason to postpone immunisation.

Immunosuppression and household contacts

Severe immunosuppression, such as chemotherapy, haematological malignancy, congenital immunodeficiency, long-term immunosuppressive therapy or advanced HIV infection, is a contraindication to most live vaccines. Non-live vaccines can still be given, though the response may be weaker. Timing around immunosuppressive treatment is a prescriber decision, so the nurse identifies the issue, holds the live vaccine and clarifies the order.

A healthy person who lives with someone immunocompromised is in a different position. CDC lists an immunodeficient household contact as a misperceived contraindication to MMR and varicella, so siblings and carers can usually be vaccinated, which helps protect the vulnerable person. Questions test whether you apply the contraindication to the right individual instead of extending it to the whole family.

Before any live vaccine, the nurse screens with a standard questionnaire: current illness, pregnancy or plans to conceive soon, cancer treatment, steroids or other immune-suppressing medicines, recent blood products and previous reactions. A positive answer is a reason to pause and clarify with the prescriber, not to improvise a substitute product at the bedside.

Spacing and antibody products affect live vaccines more

Live injectable vaccines that are not given on the same day are generally separated by at least four weeks, because the first may blunt the response to the second. Non-live vaccines have more flexible spacing and can usually be given before, after or alongside other vaccines. Check the record before assuming a missed interval is harmless.

Blood products and immune globulin contain antibodies that can neutralise an injected live vaccine, so the timing between them follows published intervals that the prescriber or immunisation protocol applies. Inactivated vaccines are not affected in the same way. When a chart shows recent immune globulin or transfusion, flag it before giving MMR or varicella rather than proceeding by habit.

Work a hypothetical clinic scenario

Imagine an original practice question: a client at 30 weeks of gestation has no rubella immunity and asks for every vaccine she is missing. Options are giving MMR today, giving Tdap and inactivated influenza while planning MMR after birth, deferring all vaccines until delivery, or giving nasal influenza. The second option is strongest because it pairs recommended non-live vaccines with deferral of the live one.

Change the scenario: the client is not pregnant but her toddler is receiving chemotherapy. She asks whether her other child can have MMR. Declining the sibling's vaccine is tempting but incorrect, because the household contact is not the immunosuppressed person. The nurse supports vaccinating the sibling under local policy and reinforces hand hygiene and illness precautions for the family.

Sources and further reading

CDC: Contraindications and Precautions (General Best Practice Guidelines for Immunization). Live vaccines withheld in pregnancy and severe immunocompromise; immunodeficient household contact as a misperceived contraindication.

CDC: Guidelines for Vaccinating Pregnant Women. Live vaccines contraindicated in pregnancy, Tdap each pregnancy, inactivated influenza, postpartum MMR and waiting before conception.

CDC Pink Book: Chapter 2, General Best Practice Guidance for Immunization. Four-week spacing of live injected vaccines, antibody product interference and live vaccine risk in immunosuppression.